Research Article
Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer
Figure 4
Survival analysis of MAL2 expression in terms of overall survival. Kaplan—Meier survival curve analysis of all tumors (a), subgroup analysis of old patients (b), clinical stage I/II and III/IV (c and d), subgroup analysis of T classification (T1/T2 and T3/T4) (e and f), patients with lymphatic invasion (g), patients with nondistant metastasis (h), and patients with ER-, PR-, and HER2-positive status (i—k, respectively).
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |
(j) |
(k) |